{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34732846",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "10",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41565-021-01001-3"
    ],
    "Journal": {
      "ISSN": "1748-3395",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "11",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov"
        }
      },
      "Title": "Nature nanotechnology",
      "ISOAbbreviation": "Nat Nanotechnol"
    },
    "ArticleTitle": "The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines.",
    "Pagination": {
      "StartPage": "1169",
      "EndPage": "1171",
      "MedlinePgn": "1169-1171"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. paolo.bigini@marionegri.it."
          }
        ],
        "LastName": "Bigini",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [
          "0000-0003-1014-6225"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy."
          }
        ],
        "LastName": "Gobbi",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy."
          }
        ],
        "LastName": "Bonati",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy."
          }
        ],
        "LastName": "Clavenna",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy."
          }
        ],
        "LastName": "Zucchetti",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy."
          }
        ],
        "LastName": "Garattini",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [
          "0000-0002-8754-0899"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pharmaceutical and Pharmacological Sciences Department, University of Padova, Padua, Italy. gianfranco.pasut@unipd.it."
          }
        ],
        "LastName": "Pasut",
        "ForeName": "G",
        "Initials": "G"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nat Nanotechnol",
    "NlmUniqueID": "101283273",
    "ISSNLinking": "1748-3387"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "3WJQ0SDW1A",
      "NameOfSubstance": "Polyethylene Glycols"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "chemically induced"
      ],
      "DescriptorName": "Anaphylaxis"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [
        "pathology",
        "virology"
      ],
      "DescriptorName": "Drug Hypersensitivity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nanotechnology"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Polyethylene Glycols"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Vaccination"
    }
  ]
}